Hirsch Stanley
Insider CIK 1727864 · MNLO Director · FOMX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MNLO Menlo Therapeutics Inc. | A Award | 2020-04-03 | 2020-04-07 | 71,303 | — | $0 | 201,410 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-04-03 | 2020-04-07 | 220,496 | — | $0 | 328,609 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-04-03 | 2020-04-07 | 63,844 | — | $0 | 130,107 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 49,766 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 27,000 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 82,153 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 15,994 | — | $0 | 15,994 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 29,481 | — | $0 | 29,481 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 48,667 | — | $0 | 48,667 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer | 2020-03-09 | 2020-03-11 | 52,842 | — | $0 | 241,516 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer | 2020-03-09 | 2020-03-11 | 59,016 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer | 2020-03-09 | 2020-03-11 | 182,500 | — | $0 | 59,016 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-03-09 | 2020-03-11 | 108,113 | — | $0 | 108,113 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-03-09 | 2020-03-11 | 31,303 | — | $0 | 31,303 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-03-09 | 2020-03-11 | 34,960 | — | $0 | 66,263 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2020-02-27 | 2020-03-03 | 42,493 | — | $0 | 111,858 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | M Exercise deriv | 2019-11-04 | 2019-11-05 | 32,500 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | M Exercise | 2019-11-04 | 2019-11-05 | 32,500 | $0.62 | $20.1K | 182,500 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | M Exercise deriv | 2019-10-15 | 2019-10-17 | 90,000 | — | $0 | 32,500 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | M Exercise | 2019-10-15 | 2019-10-17 | 90,000 | $0.62 | $55.8K | 150,000 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | M Exercise deriv | 2019-08-13 | 2019-08-14 | 60,000 | — | $0 | 122,500 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | M Exercise | 2019-08-13 | 2019-08-14 | 60,000 | $0.62 | $37.2K | 60,000 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2019-05-16 | 2019-05-20 | 56,391 | — | $0 | 69,365 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | M Exercise deriv | 2018-07-13 | 2018-07-13 | 1,616 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | M Exercise | 2018-07-13 | 2018-07-13 | 1,616 | — | $0 | 12,974 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | X Exercise deriv | 2018-05-13 | 2018-05-31 | 6,224 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | X Exercise | 2018-05-13 | 2018-05-31 | 6,224 | $5.04 | $31.4K | 12,672 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | S Sale | 2018-05-13 | 2018-05-31 | 6,164 | $5.09 | $31.4K | 6,508 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award deriv | 2018-05-08 | 2018-05-10 | 49,766 | — | $0 | 49,766 | SEC↗ |